Bismuth-based nanosystems for precise tumor theranostics: Recent progress, challenges and perspectives
Theranostics · 2026
DOI: 10.7150/thno.140822 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, 2026. Verfasst von Haohao Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Biological and Chemical Engineering, Qilu Institute of Technology, Jinan 250200, China. Hauptthemen laut MEDLINE: Theranostic Nanomedicine, Bismuth, Neoplasms, Nanostructures. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Precision tumor diagnosis and treatment are constrained by inaccurate early diagnosis, therapeutic resistance, immunosuppressive tumor microenvironments, and toxic side effects of drugs, resulting in unsatisfactory efficacy of monotherapies. Multifunctional nanoplatforms capable of integrating multimodal imaging, synergistic therapy and immune regulation constitute a core research focus in precision oncology. Bi-based nanomaterials exhibit high X-ray attenuation, tunable band structures, excellent photoacoustic/catalytic performance and controllable degradability, rendering them suitable for imaging-guided precision tumor theranostics. This article systematically reviews four categories of Bi-based nanomaterials: elemental/single-phase, heterostructures, core-shell structures, and Bi-based/containing MOFs. We summarize strategies for structural modification and structure-activity relationship optimization, elaborate their advantages in multimodal imaging, as well as synergistic anti-tumor mechanisms combining phototherapy, radiotherapy, sonodynamic therapy and immunotherapy, including activation of regulated cell death, tumor microenvironment remodeling, and tumor growth inhibition and anti-metastasis effects. Furthermore, the bottlenecks hindering their clinical translation are outlined, and prospects for the development of precision nanotheranostics are proposed. This work provides theoretical references for the clinical translation of Bi-based nanomaterials for tumor theranostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biological and Chemical Engineering, Qilu Institute of Technology, Jinan 250200, China.
- College of Chemistry, Beijing University of Chemical Technology, Beijing 10010, China.
Zitieren
APA
Zhang, H., Guo, M., Kong, Z., Ma, Y., Hong, L., Pang, M., Wang, Z., Yang, M., An, J., Pak, Y. L., & Song, J. (2026). Bismuth-based nanosystems for precise tumor theranostics: Recent progress, challenges and perspectives. Theranostics. https://doi.org/10.7150/thno.140822
Vancouver
Zhang H, Guo M, Kong Z, Ma Y, Hong L, Pang M, et al. Bismuth-based nanosystems for precise tumor theranostics: Recent progress, challenges and perspectives. Theranostics. 2026. doi:10.7150/thno.140822
BibTeX
@article{Zhang2026,
author = {Zhang, Haohao and Guo, Mengge and Kong, Zhen and Ma, Yujie and Hong, Laixin and Pang, Mingyuan and Wang, Zimai and Yang, Min and An, Juan and Pak, Yen Leng and Song, Jibin},
title = {Bismuth-based nanosystems for precise tumor theranostics: Recent progress, challenges and perspectives},
journal = {Theranostics},
year = {2026},
doi = {10.7150/thno.140822}
}
EUVIMED